ALVO
USDAlvotech Ordinary Shares
即時價格
價格圖表
關鍵指標
市場指標
開盤
$9.010
最高
$9.220
最低
$8.944
交易量
0.20M
公司基本面
市值
2.8B
行業
Drug Manufacturers - Specialty & Generic
國家
Luxembourg
交易統計
平均交易量
0.21M
交易所
NGM
貨幣
USD
52週範圍
相關新聞
Notification for the purposes of article 13 of the Luxembourg law of 11 January 2008 on transparency requirements for issuers
Luxembourg (July 3, 2025) – Alvotech S.A. announces that on June 25, 2025, the proportion of own shares held by Alvotech S.A. reached 6.73%, crossing above the 5% threshold of the total number of voting rights. The above
Alvotech's Lenders Lower Interest on Senior Secured Term Loan Facility
REYKJAVIK, ICELAND (June 26, 2025) — Alvotech (NASDAQ:ALVO, ALVO SDB, the "Company")), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today
Main Results of 2025 Annual and Extraordinary General Meeting
REYKJAVÍK, Iceland and LUXEMBOURG, June 25, 2025 (GLOBE NEWSWIRE) -- The 2025 Annual and Extraordinary General Meeting (the "2025 AGM") of Alvotech (the "Company") was held on June 25, 2025, at Arendt
Positive Top Line Results from Confirmatory Efficacy Study for Proposed Biosimilar to Xolair® (omalizumab)
REYKJAVIK, Iceland and PISCATAWAY, N.J. and LONDON, June 25, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ:ALVO), a global biotech company specializing in the development and manufacturing of biosimilar medicines for
European Medicines Agency Recommends Market Approval of AVT06, Alvotech's Proposed Biosimilar to Eylea® (aflibercept)
REYKJAVIK, ICELAND and LONDON, UK (June 23, 2025) — Alvotech (NASDAQ:ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma, a UK
相關股票
保持更新
設定價格提醒，獲取AI分析更新和即時市場新聞。